AC Immune News and Activities

AC Immune is a company listed under the stock ticker ACIU (CH).

View the org chart displaying its 20 main executives

Most searched biographies at AC Immune

• Martin Zügel, Chairman of the Board and Interim Chief Executive O...
• Roy Twyman, Director
• Carl June, Director

Popular executive movements at AC Immune

• Martin Zügel who was Chairman of the Board and Director, becomes Chairman of the Board and Interim Chief Executive Officer  (posted on May 12 2026).
• Andrea Pfeifer, Chief Executive Officer and Director, has left the company  (posted on May 12 2026).

Create your alert
to follow the executive moves at AC Immune.

AC Immune has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by AC Immune

• Detailed Data From the Phase II Crenezumab Alzheimer’s Prevention Initiative Study in Autosomal Dominant Alzheimer’s Disease Presented at AAIC | AC Immune SA
• AC Immune Reports Second Quarter 2022 Financial Results and Provides Corporate Update | AC Immune SA
• AC Immune Announces Upcoming Presentations at the Alzheimer’s Association International Conference | AC Immune SA
• AC Immune Holds Annual General Meeting of Shareholders | AC Immune SA
• AC Immune Provides Update on Alzheimer’s Prevention Initiative Study Evaluating Crenezumab in Autosomal Dominant Alzheimer’s Disease | AC Immune SA
• AC Immune to Present at the 2022 Jefferies Healthcare Conference | AC Immune SA
• AC Immune CEO Andrea Pfeifer Receives Aenne Burda Award | AC Immune SA
• AC Immune’s Anti-Abeta Vaccine Results from Phase 1b Study in Down Syndrome Published in JAMA Neurology | AC Immune SA
• AC Immune Reports First Quarter 2022 Financial Results and Provides Corporate Update | AC Immune SA
• AC Immune to Present at the B. Riley Annual Neuro & Ophthalmology Virtual Investor Conference | AC Immune SA
• View more press releases Close

Social media about AC Immune

• AC Immune on Wikipedia, Google News & Yahoo Finance
• AC Immune on LinkedIn, X (Twitter) & YouTube